Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation.
- DOI
- 10.1056/nejmoa2310234
- Published
- 2024 Jan 11
- Container
- The New England journal of medicine
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1056/nejmoa2310234,
title = {Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation.},
author = {Healey JS and Lopes RD and Granger CB and Alings M and Rivard L and McIntyre WF and Atar D and Birnie DH and Boriani G and Camm AJ and Conen D and Erath JW and Gold MR and Hohnloser SH and Ip J and Kautzner J and Kutyifa V and Linde C and Mabo P and Mairesse G and Benezet Mazuecos J and Cosedis Nielsen J and Philippon F and Proietti M and Sticherling C and Wong JA and Wright DJ and Zarraga IG and Coutts SB and Kaplan A and Pombo M and Ayala-Paredes F and Xu L and Simek K and Nevills S and Mian R and Connolly SJ and ARTESIA Investigators},
year = {2024},
journal = {The New England journal of medicine},
doi = {10.1056/nejmoa2310234},
url = {https://doi.org/10.1056/nejmoa2310234}
}RIS
TY - JOUR TI - Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation. AU - Healey JS AU - Lopes RD AU - Granger CB AU - Alings M AU - Rivard L AU - McIntyre WF AU - Atar D AU - Birnie DH AU - Boriani G AU - Camm AJ AU - Conen D AU - Erath JW AU - Gold MR AU - Hohnloser SH AU - Ip J AU - Kautzner J AU - Kutyifa V AU - Linde C AU - Mabo P AU - Mairesse G AU - Benezet Mazuecos J AU - Cosedis Nielsen J AU - Philippon F AU - Proietti M AU - Sticherling C AU - Wong JA AU - Wright DJ AU - Zarraga IG AU - Coutts SB AU - Kaplan A AU - Pombo M AU - Ayala-Paredes F AU - Xu L AU - Simek K AU - Nevills S AU - Mian R AU - Connolly SJ AU - ARTESIA Investigators PY - 2024 JO - The New England journal of medicine DO - 10.1056/nejmoa2310234 UR - https://doi.org/10.1056/nejmoa2310234 ER -
APA
JS, H., RD, L., CB, G., M, A., L, R., WF, M., D, A., DH, B., G, B., AJ, C., D, C., JW, E., MR, G., SH, H., J, I., J, K., V, K., C, L., P, M., G, M., J, B. M., J, C. N., F, P., M, P., C, S., JA, W., DJ, W., IG, Z., SB, C., A, K., M, P., F, A., L, X., K, S., S, N., R, M., SJ, C., & Investigators, A. (2024). Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation.. The New England journal of medicine. https://doi.org/10.1056/nejmoa2310234
Source records
- pubmed · retrieved 2026-09-26T08:31:26.391Z